Materias dentro de su búsqueda.
Mostrando 3,001 - 3,020 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 0.35s Limitar resultados
  1. 3001
    “…PURPOSE: Using a real-world database with matched genomic-transcriptomic molecular data, we sought to characterize the distinct molecular correlates underlying clinical differences between patients with young-onset pancreatic cancer (YOPC; younger than 50 years) and patients with average-onset pancreatic cancer (AOPC; 70 years and older). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer
  2. 3002
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A commentary on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’
  3. 3003
    “…RESULTS: Of 1006 pancreatic cancer patients, 86 (8.5%) had VTE at baseline, and seven (0.7%) had symptomatic VTE. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
  4. 3004
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
  5. 3005
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and Caveolin-1
  6. 3006
    “…Previously we isolated a susceptibility locus for familial pancreatic cancer to chromosome location 4q32–34. In this study, our goal was to discover the identity of the familial pancreatic cancer gene on 4q32 and determine the function of that gene. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism
  7. 3007
    “…Since EGF, TGF-alpha and IGF-1 are considered to play an important role in the proliferation of pancreatic cancer cells, we studied the effects of tyrphostins on the growth of three human pancreatic cancer cell lines (MiaPaCa-2, Panc-1 and CAV). …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
  8. 3008
    por Ching, C. K., Rhodes, J. M.
    Publicado 1990
    Enlace del recurso
    Enlace del recurso
    Texto
    Identification of the peanut-agglutinin binding pancreatic cancer serum marker in pancreatic tissue extracts.
  9. 3009
    “…There were 54 cases of pancreatic cancer ascertained from the Israel Cancer Registry during follow-up. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study
  10. 3010
    Enlace del recurso
    Enlace del recurso
    Texto
    Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study.
  11. 3011
    Enlace del recurso
    Enlace del recurso
    Texto
    Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy.
  12. 3012
    “…Our data suggest that vitamin D analogues together with retinoids inhibit the growth of human pancreatic cancer cells. However, in vivo studies are necessary to examine the potential use of retinoids and vitamin D analogues on pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells.
  13. 3013
    “…A multi-institutional phase II trial of this regimen in patients with locally advanced pancreatic cancer is now underway.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
  14. 3014
    por Stevens, R J, Roddam, A W, Beral, V
    Publicado 2007
    “…We conducted a systematic review of the risk of pancreatic cancer in people with type I and young-onset diabetes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis
  15. 3015
    “…The PMX and CPT-11 combination displays a strong schedule-independent synergistic cytotoxic activity against pancreatic cancer, providing experimental basis for its clinical testing as salvage chemotherapy in pancreatic cancer patients.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
  16. 3016
    “…Pancreatic ductal adenocarcinoma, called pancreatic cancer, is a highly aggressive cancer that is characterised by its avascular structure, which results in a severe hypoxic environment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer
  17. 3017
    “…To determine the role of NRP-1 in pancreatic cancer, NRP-1 was stably transfected into the human pancreatic cancer cell line FG. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells
  18. 3018
    “…In this study, we demonstrate, for the first time, up-regulation of telomerase activity in human pancreatic cancer cells treated with etoposide, a topoisomerase II inhibitor. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide
  19. 3019
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients
  20. 3020
    “…Pancreatic cancer is an aggressive and potent disease, which is largely resistant to conventional forms of treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?
Herramientas de búsqueda: RSS